<img alt="" height="1" width="1" />
FDA OKs Abilify for autism-linked irritability
BusinessWeek
The US Food and Drug Administration has approved top-selling Abilify as a treatment for autism-related irritability in children from the ages of 6 to 17, drug maker Bristol-Myers Squibb Co. said Friday. Bristol-Myers and Otsuka Pharmaceutical Co., ...
UPDATE 1-FDA oks Abilify for child autism irritabilityReuters
The drug Abilify has been approved to temper the symptoms of autismExaminer.com
FDA Approves Bristol-Myers&#39; Abilify To Treat Irritabilty In Pediatric Patients ...RTT News
WELT ONLINE
all 25 news articles &raquo;


More...